Summary of Study ST002392

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR001539. The data can be accessed directly via it's Project DOI: 10.21228/M8RT4H This work is supported by NIH grant, U2C- DK119886.


This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002392
Study TitleCandida albicans NMR exometabolome
Study SummaryThe NMR-based metabolomics analysis of 95 C. albicans isolates using the culture supernatants collected after 14h of incubation. The processed data are used as binns or as annotated and quantified metabolites data for study of the isolates variability within and between genomic clades.
DepartmentOmics Hub
Last NameBunescu
First NameAndrei
Address40, avenue Tony Garnier, Lyon, 69007
Submit Date2022-12-06
Raw Data AvailableYes
Raw Data File Type(s)fid
Analysis Type DetailNMR
Release Date2023-06-06
Release Version1
Andrei Bunescu Andrei Bunescu application/zip

Select appropriate tab below to view additional metadata details:


Project ID:PR001539
Project DOI:doi: 10.21228/M8RT4H
Project Title:Clade delineation and isolate-specific variability of Candida albicans exometabolome
Project Summary:The study includes the NMR-based metabolomics analysis of 95 C. albicans isolates from most of representative genomic clades including the so called clade 13, C. africana. The metabolomics study is based on the supernatants of C. albicans growth after 14h of incubation. All generated data were then quantified with the help of Chenomx NMR suite.
Department:Omics Hub
Last Name:Bunescu
First Name:Andrei
Address:40, avenue Tony Garnier, Lyon, 69007
Phone:+33 (0)
Funding Source:We received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie action, Innovative Training Network: FunHoMic; grant N° 812969. BIOASTER received funding from the French Government ‘Investissement d'Avenir’ program (Grant No. ANR-10-AIRT-03).